1. Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study. (20th September 2022) Authors: Shi, Guo‐Ming; Huang, Xiao‐Yong; Wen, Tian‐Fu; Song, Tian‐Qiang; Kuang, Ming; Mou, Hai‐Bo; Bao, Le‐Qun; Zhao, Hai‐Tao; Zhao, Hong; Feng, Xie‐Lin; Zhang, Bi‐Xiang; Peng, Tao; Zhang, Yu‐Bao; Li, Xiang‐Cheng; Yu, Hong‐Sheng; Cao, Yu; Liu, Lian‐Xin; Zhang, Ti; Wang, Wei‐Lin; Ran, Jiang‐Hua Journal: Cancer medicine Issue: Volume 12:Number 4(2023) Page Start: 4137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗